Mirum researches, develops and commercializes novel therapies for the treatment of liver diseases.
Read moreAnnual Revenue
$19.1M
Mirum's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 8.1B. Over the last three quarters, Mirum's revenue has decreased by 71.5%. Specifically, in Q4 2021's revenue was $3.1M; in Q3 2021, it was $5M; in Q2 2021, it was $11M.